-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
No data
undefined
Central nervous system
Acetaminophen Mannitol Injection
[Generic Name] Acetaminophen Mannitol Injection
[Approval Number] National Drug Approval Number H20223397
【Specification】100 ml: 1000 mg
【Dosage Form】Injection
Acetaminophen Mannitol Injection
[Generic Name] Acetaminophen Mannitol Injection
[Approval Number] National Drug Approval Number H20223397
【Specification】100 ml: 1000 mg
【Dosage Form】Injection
Bunan Seline Tablets
[Generic Name] Bunan Seline Tablets
[Approval Number] National Drug Approval Number H20223407
[Specification] 4mg
【Dosage Form】Tablets
Bunan Seline Tablets
[Generic Name] Bunan Seline Tablets
[Approval Number] National Drug Approval Number H20223407
[Specification] 4mg
【Dosage Form】Tablets
Dexmedetomidine Hydrochloride Injection
[Generic Name] Dexmedetomidine Hydrochloride Injection
[Approval Number] National Drug Approval No. H20223051, National Drug Approval No. H20213699
【Specification】1 ml: 0.1 mg; 2 ml: 0.2 mg
[Packaging Material] Type I borosilicate glass ampoules
【Dosage Form】InjectionDexmedetomidine Hydrochloride Injection
[Generic Name] Dexmedetomidine Hydrochloride Injection
[Approval Number] National Drug Approval No. H20223051, National Drug Approval No. H20213699
【Specification】1 ml: 0.1 mg; 2 ml: 0.2 mg
[Packaging Material] Type I borosilicate glass ampoules
【Dosage Form】Injection
Lacosamide Tablets
[Generic Name] Lacosamide Tablets
[Approval Number] National Drug Approval No. H20213763
[Specification] 50mg 100mg
[Packaging Material] PVC/PVDC aluminum-plastic blister packaging
Lacosamide Tablets
[Generic Name] Lacosamide Tablets
[Approval Number] National Drug Approval No. H20213763
[Specification] 50mg 100mg
[Packaging Material] PVC/PVDC aluminum-plastic blister packaging
Ropivacaine Hydrochloride Injection
[Generic Name] Ropivacaine Hydrochloride Injection
[Approval Number] National Drug Approval No. H20203107
[Specification] 10 ml: 100 mg
[Packaging Material] Polypropylene Ampoule
[Medical Insurance] National Medical Insurance Category B
Ropivacaine Hydrochloride Injection
[Generic Name] Ropivacaine Hydrochloride Injection
[Approval Number] National Drug Approval No. H20203107
[Specification] 10 ml: 100 mg
[Packaging Material] Polypropylene Ampoule
[Medical Insurance] National Medical Insurance Category B
SERVICE HOTLINE
Mobile site
E code
